Building Medical Affairs as a Strategic Partner in Clinical Development

Medical Affairs teams are uniquely positioned to be the ‘strategic conveners’ of all stakeholders to help strategically guide the clinical development pathway from trial conception through pre-commercialization preparation.

By the end of this webinar, attendees will learn…

  1. The benefits of early Medical Engagement in the trial design process, including protocol development, patient voice (e.g., advocacy engagement, patient ad boards, DE&I), and site selection
  2. How Medical Affairs teams can help to accelerate study execution via Clinical Trial Liaisons, Research Science Liaisons, and investigator and patient engagement
  3. The role of Medical Affairs in translating clinical insights/relationships into value for Commercial teams via pre-commercialization strategies and market preparation

This webinar will provide the Medical Affairs community with a differentiated and bold view to drive the future state of Medical Affairs and what “good” looks like regarding the role of Medical Affairs in Clinical Development.

Moderator: Colin Oliver

Moderator: Colin Oliver

Senior Managing Director, Global Medical Affairs & HEOR, Syneos Health
Speaker: Gissoo DeCotiis

Speaker: Gissoo DeCotiis

Global Head of Advocacy & Strategic Relations, Global Medical Affairs, Oncology, Daiichi Sanyko
Speaker: Everest Nwakamma

Speaker: Everest Nwakamma

Sr Director, Global Oncology MSL Excellence, Daiichi Sankyo
Speaker: Patrick Nealon

Speaker: Patrick Nealon

Senior Vice President Clinical Development Operations, Aura Biosciences
Speaker: Meredith Wilson

Speaker: Meredith Wilson

SVP, Patient Advocacy, Syneos Health